Adhesys Medical In The News


Aachen, 09. February 2016 – On January 22nd, Medical Adhesive Revolution was renamed Adhesys Medical. The rebranding is reflected in a new logo and corporate design as well as the launch of a new company website www.adhesys-medical.com. The rebranding is part of a broader initiative to prepare for the next stage of development: “This year, we shall transition from an R&D-focused operation into a commercial stage company“, says Alexander Schueller.

“Adhesys”, the new company name, is derived from the two terms: Adhesives and Systems. “Adhesives” describes the core of the technology, a polyurethane-based medical glue, while “Systems”, furthermore, reflects the potential of the technology as a platform for development of a great variety of products and applications. So far, Adhesys Medical has developed two first-of-its-kind biodegradable, polyurethane-based medical adhesives – one for use inside the human body and another for topical use.

“Adhesys Medical” therefore represents the company’s vision to enable game-changing advancements in surgery and wound closure by providing surgeons with unique, best-in-class technologies in order to improve patient outcomes and save lives.

The change of name and rebranding also reflect the development of Adhesys Medical from a small startup founded in 2013 in Aachen, Germany to the evolving and international company that it is today.

About Adhesys Medical 

Adhesys Medical, formerly Medical Adhesive Revolution, is a medical device company based in Germany and the United States and is dedicated to developing one-of-a-kind, polyurethane-based surgical sealants. Based on a technology that has been developed since 2007, the company was founded in 2013 in Aachen, Germany to bring the sealants to market. The company owns all patents regarding the technology and has completed the development of two product lines: one for topical use to close wounds of the skin, such as surgical incisions and laparoscopic incisions that have easily approximated skin edges, and one for internal use to seal areas of leakage, reinforce suture lines, and stop bleeding.

In early 2017, Adhesys Medical was acquired by the Aachen-based pharmaceutical company Grünenthal GmbH and continues to operate as a wholly-owned subsidiary of the Grünenthal Group.

More information: www.adhesys-medical.com

Follow us on Twitter


Adhesys Medical GmbH

Pauwelsstraße 17

52074 Aachen

E-Mail info.eu@adhesys-medical.com

Phone +49 (0) 241 412 50320